Clinical Multimodal and Assessment of Response
Room 4A Wednesday 14:00 - 16:00



Prog #


14:00 3478 25

Quantification of Response of Hepatocellular Carcinoma(HCC) to Bevacizumab by Contrast Enhanced MRI

Emil Cohen1, Jonathan Schwartz1, John Mandeli2, Deborah Lehrer2

1Mount Sinai School of Medicine, New York, New York, USA; 2Mount Sinai Medical Center, New York, New York, USA
14:00 3479 26

Oncological Imaging: Whole-Body MRI for Staging of Patients with Malignant Lymphoma

Bernd B. Frericks1, Bernhard Meyer1, Thomas Albrecht1, Alexander Huppertz2, Karl J. Wolf1, Frank K. Wacker1

1Charité, Campus Benjamin Franklin, Berlin, Germany; 2Siemens, Berlin, Germany

14:00 3480 24

MRI Compared to CT in Whole-Body Slice Area Measurements

Joel Kullberg1, Jan-Erik Angelhed2, John Brandberg2, 3, Hans Frimmel1, Eva Bergelin2, Lena Strid2, Håkan Ahlström1,

Lars Johansson1, Lars Lönn2, 3

1Uppsala University Hospital, Uppsala, Sweden; 2The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden;

3Sahlgrenska University Hospital, Göteborg, Sweden

14:30 3481 24

Whole-Body Pet-MRI - Co-Registration and Image Fusion in Pattients with Cancer

Roberto Cortes Domingues1, 2, Michel Pontes Carneiro3, Luiz Celso Hygino da Cruz4, Karla Sideira Porto4,

Leonardo Pitanga4, Rômulo Cortes Domingues4, Romeu Cortes Domingues4

1CDPI / Multi-Imagem, Rio de Janeiro, RJ, Brazil; 2Multimagem Pet, Rio de Janeiro, RJ, Brazil; 3Multimagem PET, Rio de Janeiro, RJ, Brazil; 4CDPI, Rio de Janeiro, RJ, Brazil
14:30 3482 26

Evaluation Early Response of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolizatio

(TACE) with 1H Magnetic Resonance Spectroscopy In Vivo

Wu Bin1, Peng Weijuns1

1Cancer Hospital, Shanghai, People’s Republic of China
14:30 3483 25

Neoadjuvant Chemotherapy in Breast Cancer: Prediction of Post-Surgery Disease-Free Survival Using DCE

MRI, Water ADC Mapping and Proton Spectroscopic Imaging

David John Manton1, Anne Hubbard2, Martin Lowry1, Anthony Maraveyas1, Martin D. Pickles1, Daniel J. Tozer3, Lindsay

W. Turnbull1

1University of Hull, Hull, East Yorkshire, UK; 2Hull and East Yorkshire Hospitals NHS Trust, Hull, East Yorkshire, UK;

3Institute of Neurology, London, UK

15:00 3484 25

Tumor Volume Regression During Therapy in Cervical Cancer: Does the Tumor Regress Faster with Combined

Radiation/Chemotherapy Than with Radiation Therapy Alone?

Nina A. Mayr1, Jian Zhong Wang1, William TC Yuh1, Joseph F. Montebello1, Vincent A. Magnotta2,

Kenneth F. Wegner3, Susan M. Edwards3

1The Ohio State University, Columbus, Ohio, USA; 2University of Iowa, Iowa City, Iowa, USA; 3University of Oklahoma

Health Science Center, Oklahoma City, Oklahoma, USA

15:00 3485 26

Diffusion-Weighted and Dynamic Contrast-Enhanced Imaging at 3.0 T of Prostate Cancer

Uulke Age van der Heide1, Cecile R.L.P.N. Jeukens1, Peter R. Luijten1, Marco van Vulpen1

1UMC-Utrecht, Utrecht, Netherlands
15:00 3486 24

Whole Body MR Imaging vs. FDG-PET: Comparison of Diagnosis Accuracy of M-Stage in Lung Cancer Patients

Yoshiharu Ohno1, Hisanobu Koyama1, Munenobu Nogami1, Hideaki Kawamitsu2, Daisuke Takenaka1,

Kazuro Sugimura1

1Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan; 2Kobe University Hospital, Kobe, Hyogo, Japan
15:30 3487 24

Combined Stereoscopic X-Ray and MR Imaging (“XMR”) for the Evaluation of Prostate Brachytherapy Implants

with Comparison to Standard CT-Based Dosimetry

Peter Acher1, 2, Kawal Rhode1, Stephen Morris2, Marc Miquel1, Kate Mcleish1, Ronald Beaney2, Charles Deehan2, Rick

Popert2, Stephen Keevil1

1King's College London, London, England, UK; 2Guy's & St Thomas' NHS Foundation Trust, London, England, UK
15:30 3488 26

Combined MRI/MRS Protocol for Specificity Improvement in Breast Cancer Detection

Luminita Alina Tudorica1, Paul Fisher1, Khaldoon Dulaimy1, Brian O'Hea1, Terry Button1, Wei Huang2

1State University of New York, Stony Brook, New York, USA; 2Memorial Sloan-Kettering Cancer Center, New York, New

York, USA

15:30 3489 25

Dynamic Contrast-Enhanced MRI as a Predictor of Residual Tumor After Photodynamic Therapy with TOOKAD

(WST09) for Locally Recurrent Prostate Carcinoma After Radiation Therapy

Masoom A. Haider1, Brian Wilson2, Sean Davidson2, Robert Weersink2, Mark Gertner2, Andrew Evans2, Ants Toi1, John


1University of Toronto, Toronto, Ontario, Canada; 2Princess Margaret Hospital, Toronto, Ontario, Canada; 3University Health Network, University of Toronto, Toronto, Ontario, Canada